Basics |
Axogen, Inc. Common Stock
AxoGen Inc is a medical technology company dedicated to peripheral nerve repair. It provide products and education to improve surgical treatment algorithms for peripheral nerve injuries.
|
IPO Date: |
January 1, 1987 |
Sector: |
Healthcare |
Industry: |
Health Care Equipment and Supplies |
Market Cap: |
$514.65M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.31 | 2.46%
|
Avg Daily Range (30 D): |
$0.30 | 2.27%
|
Avg Daily Range (90 D): |
$0.37 | 2.32%
|
Institutional Daily Volume |
Avg Daily Volume: |
.24M |
Avg Daily Volume (30 D): |
.49M |
Avg Daily Volume (90 D): |
.42M |
Trade Size |
Avg Trade Size (Sh.): |
94 |
Avg Trade Size (Sh.) (30 D): |
59 |
Avg Trade Size (Sh.) (90 D): |
56 |
Institutional Trades |
Total Inst.Trades: |
1,092 |
Avg Inst. Trade: |
$1.27M |
Avg Inst. Trade (30 D): |
$1.26M |
Avg Inst. Trade (90 D): |
$1.44M |
Avg Inst. Trade Volume: |
.09M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.29M |
Avg Closing Trade (30 D): |
$1.3M |
Avg Closing Trade (90 D): |
$1.48M |
Avg Closing Volume: |
75.61K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-.15
|
$-.08
|
$.01
|
Diluted EPS
|
$-.15
|
$-.08
|
$.01
|
Revenue
|
$ 194.52M
|
$ 48.56M
|
$ 49.41M
|
Gross Profit
|
$ 144.29M
|
$ 34.93M
|
$ 37.58M
|
Net Income / Loss
|
$ -7.16M
|
$ -3.83M
|
$ .45M
|
Operating Income / Loss
|
$ -.39M
|
$ -1.66M
|
$ 2.02M
|
Cost of Revenue
|
$ 50.23M
|
$ 13.63M
|
$ 11.83M
|
Net Cash Flow
|
$ 2.38M
|
$ -9.46M
|
$ 8.89M
|
PE Ratio
|
|
|
|
|